Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division
Cell cycle progression and lipid metabolism are well-coordinated processes required for proper cell proliferation. In liver diseases that arise from dysregulated lipid metabolism, hepatocyte proliferation is diminished. To study the outcome of CDK1 loss and blocked hepatocyte proliferation on lipid...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
eLife Sciences Publications Ltd
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/800dcd51bf63414c82eae688da8bc038 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:800dcd51bf63414c82eae688da8bc038 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:800dcd51bf63414c82eae688da8bc0382021-11-19T12:15:20ZRemodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division10.7554/eLife.638352050-084Xe63835https://doaj.org/article/800dcd51bf63414c82eae688da8bc0382020-12-01T00:00:00Zhttps://elifesciences.org/articles/63835https://doaj.org/toc/2050-084XCell cycle progression and lipid metabolism are well-coordinated processes required for proper cell proliferation. In liver diseases that arise from dysregulated lipid metabolism, hepatocyte proliferation is diminished. To study the outcome of CDK1 loss and blocked hepatocyte proliferation on lipid metabolism and the consequent impact on whole-body physiology, we performed lipidomics, metabolomics, and RNA-seq analyses on a mouse model. We observed reduced triacylglycerides in liver of young mice, caused by oxidative stress that activated FOXO1 to promote the expression of Pnpla2/ATGL. Additionally, we discovered that hepatocytes displayed malfunctioning β-oxidation, reflected by increased acylcarnitines (ACs) and reduced β-hydroxybutyrate. This led to elevated plasma free fatty acids (FFAs), which were transported to the adipose tissue for storage and triggered greater insulin secretion. Upon aging, chronic hyperinsulinemia resulted in insulin resistance and hepatic steatosis through activation of LXR. Here, we demonstrate that loss of hepatocyte proliferation is not only an outcome but also possibly a causative factor for liver pathology.Jin Rong OwMatias J CaldezGözde ZaferJuat Chin FooHong Yu LiSoumita GhoshHeike WollmannAmaury Cazenave-GassiotChee Bing OngMarkus R WenkWeiping HanHyungwon ChoiPhilipp KaldiseLife Sciences Publications Ltdarticleliverlipid metabolisminsulin resistancehepatic steatosiscell cycleCDK1MedicineRScienceQBiology (General)QH301-705.5ENeLife, Vol 9 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
liver lipid metabolism insulin resistance hepatic steatosis cell cycle CDK1 Medicine R Science Q Biology (General) QH301-705.5 |
spellingShingle |
liver lipid metabolism insulin resistance hepatic steatosis cell cycle CDK1 Medicine R Science Q Biology (General) QH301-705.5 Jin Rong Ow Matias J Caldez Gözde Zafer Juat Chin Foo Hong Yu Li Soumita Ghosh Heike Wollmann Amaury Cazenave-Gassiot Chee Bing Ong Markus R Wenk Weiping Han Hyungwon Choi Philipp Kaldis Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division |
description |
Cell cycle progression and lipid metabolism are well-coordinated processes required for proper cell proliferation. In liver diseases that arise from dysregulated lipid metabolism, hepatocyte proliferation is diminished. To study the outcome of CDK1 loss and blocked hepatocyte proliferation on lipid metabolism and the consequent impact on whole-body physiology, we performed lipidomics, metabolomics, and RNA-seq analyses on a mouse model. We observed reduced triacylglycerides in liver of young mice, caused by oxidative stress that activated FOXO1 to promote the expression of Pnpla2/ATGL. Additionally, we discovered that hepatocytes displayed malfunctioning β-oxidation, reflected by increased acylcarnitines (ACs) and reduced β-hydroxybutyrate. This led to elevated plasma free fatty acids (FFAs), which were transported to the adipose tissue for storage and triggered greater insulin secretion. Upon aging, chronic hyperinsulinemia resulted in insulin resistance and hepatic steatosis through activation of LXR. Here, we demonstrate that loss of hepatocyte proliferation is not only an outcome but also possibly a causative factor for liver pathology. |
format |
article |
author |
Jin Rong Ow Matias J Caldez Gözde Zafer Juat Chin Foo Hong Yu Li Soumita Ghosh Heike Wollmann Amaury Cazenave-Gassiot Chee Bing Ong Markus R Wenk Weiping Han Hyungwon Choi Philipp Kaldis |
author_facet |
Jin Rong Ow Matias J Caldez Gözde Zafer Juat Chin Foo Hong Yu Li Soumita Ghosh Heike Wollmann Amaury Cazenave-Gassiot Chee Bing Ong Markus R Wenk Weiping Han Hyungwon Choi Philipp Kaldis |
author_sort |
Jin Rong Ow |
title |
Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division |
title_short |
Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division |
title_full |
Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division |
title_fullStr |
Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division |
title_full_unstemmed |
Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division |
title_sort |
remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of cdk1 and hepatocyte division |
publisher |
eLife Sciences Publications Ltd |
publishDate |
2020 |
url |
https://doaj.org/article/800dcd51bf63414c82eae688da8bc038 |
work_keys_str_mv |
AT jinrongow remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision AT matiasjcaldez remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision AT gozdezafer remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision AT juatchinfoo remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision AT hongyuli remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision AT soumitaghosh remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision AT heikewollmann remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision AT amaurycazenavegassiot remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision AT cheebingong remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision AT markusrwenk remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision AT weipinghan remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision AT hyungwonchoi remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision AT philippkaldis remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision |
_version_ |
1718420141940670464 |